ABSTRACT The guanine insertion enzyme from Escherichia coli catalyzes exchange of guanine located at the first position of the anticodon of tRNA with radioactive guanine (N. Okada and S. Nishimura, unpublished data). tRNA isolated from various tumors, including slowly growing Morris hepatoma 7794A, incorporated considerable guanine with E. coli guanine insertion enzyme, whereas tRNA isolated from all normal tissues so far tested, except regenerating rat liver, incororated scarcely any. In the rat ascites hepatoma AH7974, the guanine was mostly incorporated into minor isoaccepting species of tRNA^sP that contained the guanine residue instead of Q base in the first position of the anticodon. This is a sensitive and easy method for identifying unique tRNA species in tumor tissues.
for identifying unique tRNA species in tumor tissues.
Many new isoaccepting tRNA species have been found in particular tissues, cells at various stages of differentiation, tumor tissues, transformed cells, and cells grown under different culture conditions (for reviews, see refs. 1-3). Various techniques have been used in attempts to detect unique tRNA species in tumor cells, and it has been found that the amount of methylated nucleosides in tRNA and the activities of tRNA methylases are generally high in tumor tissues (3, 4) . However, analyses of modified nucleosides using total unfractionated tRNA have given results dependent upon the tumor tissues examined (5) . Recently, Kuchino and Borek (6) demonstrated that the tRNAPhe that specifically appeared in Novikoff hepatoma and Ehrlich ascites tumor cells contains 1-methylguanine, unlike tRNAPhe in normal tissues. The new tRNAPhe species that appears in some tumor tissues is due to lack of modified base Y in the position next to the anticodon (7, 8) . A new isoaccepting species of tRNA has often been detected in tumor cells by analyzing changes in the chromatographic profile of amino acid acceptor activity (3) . However, new tRNA cannot always be detected in this way because the elution position of tRNA may be influenced by several factors. In addition, most methods used previously require a large quantity of material and pure species of tRNA, which are difficult to obtain from tumor tissues.
In this paper, we report a method for detecting unique tRNA species specifically present in tumor cells. We previously reported that the guanine insertion enzyme from rabbit reticulocytes, discovered by Farkas (9) , specifically catalyzes the exchange of modified base Q in Escherichia coli tRNA with guanine without breaking the polynucleotide chain (10) . A guanine insertion enzyme has also been found in other organisms, such as E. coli (N. Okada and S. Nishimura, unpublished data) and Ehrlich ascites tumor cells (11) , and an extensively purified preparation from E. coli catalyzed exchange of guanine with guanine, but not of Q base in tRNA with guanine (N.
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact.
Okada and S. Nishimura, unpublished data). With this enzyme it is easy to detect tRNA species for tyrosine, histidine, asparagine, and aspartic acid, which contain guanine instead of Q base in the first position of the anticodon. In the present work with this enzyme, much guanine was incorporated into tRNA from various tumor tissues, but scarcely any was incorporated into tRNA from normal tissues. The tRNA species that accepts guanine was purified from rat ascites hepatoma AH7974 cells and identified as a minor species of tRNAAsP containing guanine instead of Q base. Thus use of this enzyme provides a readily applicable method for clearly distinguishing tumor-specific tRNA.
MATERIALS AND METHODS
Isolation of E. coli Guanine Insertion Enzyme. Guanine insertion enzyme was isolated from cells of E. coli B harvested in the late logarithmic phase. The cells were ground with glass beads and the enzyme present in the 100,000 X g supernatant was precipitated by 50% saturation with ammonium sulfate. The precipitate dissolved in buffer A (10 mM Tris1HCl, pH 7.5/10 mM MgCl2/1 mM EDTA/6 mM 2-mercaptoethanol/ 10% by vol glycerol) was dialyzed against buffer A and loaded on a column of DEAE-cellulose (DE52). Elution was performed with linear gradient of NaCl in buffer A. The enzyme eluted with 0.2 M NaCl was collected and dialyzed against buffer A. The dialyzed preparation was fractionated by DEAE-Sephadex A-50 column chromatography using a gradient of NaCl (0-0.4 M) and pH (pH 7.5-8.8). The enzyme eluted from the column was dialyzed against buffer B (10 mM potassium phosphate buffer, pH 6.6/6 mM 2-mercaptoethanol/10% glycerol) and subjected to phosphocellulose column chromatography. The enzyme eluted with 0.3 M NaCl was used for assay. The preparation catalyzed the incorporation of 50 pmol of guanine per 1 ,ug of enzyme in 1 hr under the standard assay conditions, and was thus more than 100 times as active as the enzyme preparation isolated previously from Ehrlich ascites tumor (12) . The enzyme had no detectable RNase activity. Details of the purification procedure and properties of the enzyme will be published elsewhere.
Conditions for Assay of Guanine Insertion. For assay using the E. coli guanine insertion enzyme, the reaction mixture (0.4-1 ml) contained [1] [2] [3] [4] Other Procedures. The guanine insertion enzyme from Ehrlich ascites tumor cells was prepared as described previously (12) . Unfractionated tRNA from various mammalian tissues was isolated by homogenization of the tissues with phenol and buffer, and 2-propanol fractionation (13) . Crude rat liver aminoacyl-tRNA synthetase was prepared as described by Nishimura and Weinstein (14) . The conditions for assay of amino acid acceptor activity were described in the same paper (14) . Postlabeling of an RNase Ti digest of tRNA and fingerprint analysis by Sanger's method were carried out as described by Simsek et al. (15) . Modified nucleosides were analyzed by postlabeling as described by Silberklang et al. (16) . Rat ascites hepatoma tRNA was fractionated by reversed phase (RPC-5) column chromatography as described by Pearson et al. (17)i Purification of tRNA by two-dimensional polyacrylamide gel electrophoresis was carried out as described by Ikemura and Dahlberg (18) .
Materials. [8-14C] Guanine (55 Ci/mol) and [8-3H] GTP (12 Ci/mmol) were obtained from New England Nuclear and the Radiochemical Centre, respectively. For preparation of [8-3H] guanine, [8-3H] GTP was dissolved in 1 M HCl in a capillary tube, and the tube was sealed and heated at 100°C for 1 hr. The hydrolysate was subjected to paper chromatography in isobutyric acid and 0.5 M NH40H (5:3, vol/vol), and the spot of guanine was eluted. [y-32P]ATP used for the polynucleotide kinase reaction was prepared as described by Glynn and Chappell (19) . Unfractionated yeast tRNA was a product of Boehringer. Unfractionated E. coli tRNA was prepared from E. coli B cells by Zubay's procedure (20) . Rat liver tRNAAsP was isolated by concanavalin A-Sepharose affinity chromatography (21) 
RESULTS
The guanine insertion enzyme from E. coli catalyzes the exchange of free guanine with guanine located in the first position of the anticodon of tRNATYr, tRNAHis, tRNAAm, and tRNA'sP but not the exchange of guanine with Q base in these tRNAs (N. Okada (Fig. 1) . These results suggest that there is a Morris hepatoma 7794A was transplanted intramuscularly into the hind legs of 9-to 10-week-old Buffalo strain rats. Two months after transplantation, rats were killed by decapitation and the tumors were removed. Rabbit reticulocytes were prepared as described by Farkas and Singh (9) . Ehrlich ascites tumor and sarcoma 180 ascites tumor were transplanted into ddY and ICR mice, respectively. An established cell line of AGMK, clone C14, and simian virus 40-transformed AGMK cells, clone T22 (24), were cultivated in Eagle's medium with 10% calf serum and 5% tryptose phosphate at 37°C and harvested at confluency. SN36 is a transplantable ascites tumor derived from mouse leukemia cells, and passaged in ICR mice (25) . MM46 is a transplantable ascites tumor derived from a spontaneous mammary carcinoma in a C3H/He mouse (26) . For fractionated by RPC-5 column chromatography at pH 7.5 for characterization of the guanine-accepting tRNA species present in tumor tissues. As shown in Fig. 2A , the guanine-accepting activity was separated into several discrete fractions on the column. The main fraction (fractions 347), containing.more than 85% of the guanine acceptor activity, was eluted in the same fractions as a minor peak of aspartic acid accepting activity. Upon rechromatography of this peak on RPC-5 at pH 4.5 ( Fig. 28) , most of the guanine-accepting activity emerged from the column as a sharp peak, coinciding with aspartic acid acceptor activity but completely separated from tyrosine and histidine acceptor activities. The purity of the tRNAAP in this fraction (fractions 43-47 of Fig. 2B ) was estimated to be more than 20% in terms of guanine and aspartic acid acceptor activities, assuming that 1 A20 unit of tRNA is equal to 1.6 nmol. We conclude from these findings that the guanine-accepting tRNA species present in AH7974 cells are mostly minor isoaccepting species of tRNAISP, and that from the properties of the E. colt guanine insertion enzyme, the minor isoaccepting tRNAAsP should contain guanine instead of Q* (manQ, Q containing mannose) (21, 27) in the first position of anticodon.
To confirm the identity of the acceptor, we purified the minor tRNAAsP further by two-dimensional gel electrophoresis (18) and analyzed its nucleotide sequence by Sanger's fingerprinting technique using a post-labeled RNase T1 digestion product. Fig. 3 shows a comparison of fingerprints of the RNase T1 digest of the minor and major tRNAASP species. The two fingerprint patterns were similar, indicating that the primary structures of two tRNAAsPs are identical or that structural alterations, if any, are very small. The main differences in the patterns were that spot 1 of the major tRNAASP was missing from the minor tRNAAT, and that the latter gave two new spots (spots 2 and 3). Probably the oligonucleotide of the major tRNAhP giving spot 1 contains manQ, while the corresponding oligonucleotide of the minor tRNAAsP is hydrolyzed by RNase T1 to produce two oligonucleotides (spots 2 and 3), because replacement of manQ by G in the minor tRNAAP results in the cleavage of the oligonucleotide into two portions. For confirmation of the presence of manQ in the oligonucleotide of spot 1, it was eluted and completely hydrolyzed by RNase T2; the resulting 3'-nucleotides were converted to nucleoside 5',3'-diphosphates with T4 polynucleotide kinase and [-y-32P]ATP; the 5'-32P-labeled nucleoside diphosphates were converted to 5'-mononucleotides by treatment with nuclease P1; and the 32P-labeled 5'-nucleotides were analyzed by two-dimensional thin-layer chromatography (16, 23) . Fig. 4 shows that 5'-phosphate of modified nucleoside manQ was clearly detected in the oligonucleotide of spot 1. by RPC-5 column chromatography at pH 7.5. tRNA (1000 A260 units) was fractionated by RPC-5 column chromatography (1.5 X 85 cm). Linear gradient elution was carried out using 1 liter of 10 mM Tris-HCl, pH 7.5/10 m MgCl2/1 mM 2-mercaptoethanol/500 mM NaCl in the mixing chamber, and 1 liter of 10 mM Tris-HCl, pH 7.5/10 mM MgCl2/1 mM 2-mercaptoethanol/900 mM NaCl in the reservoir. The flow rate was 50 ml/hr. Effluent fractions collected were 20 ml. (B) Second fractionation by RPC-5 column chromatography at pH 4.5. Guanine-accepting tRNA from the first column of RPC-5 (80 A260 units, fractions 34-37 of A) was loaded on a second column (0.8 X 60 cm). Linear gradient elution was performed with 250 ml of 10 mM sodium acetate buffer, pH 4.5/10 mM MgCI2/2 mM 2-mercaptoethanol/500 mM NaCl in the mixing chamber, and 250 ml of 10 mM sodium acetate buffer, pH 4.5/10 mM MgCl2/2 mM 2-mercaptoethanol/1 M NaCl in the reservoir. The flow rate was 20 ml/hr, and 5-ml fractions were collected. Guanine Insertion Reaction with Ehrlich Ascites Tumor Enzyme. Itoh et al. (11, 12) reported that the guanine insertion enzyme isolated from Ehrlich ascites tumor cells specifically catalyzed the incorporation of guanine into homologous tRNA but not into normal mouse liver tRNA. Because the Ehrlich ascites tumor enzyme catalyzes exchange of Q base in E. coli tRNA with guanine, unlike the E. coli guanine insertion enzyme, the question arises of whether the only species of Ehrlich ascites tumor tRNA that act as acceptors in the guanine insertion reaction are those with guanine instead of Q. To answer this question, we fractionated Ehrlich ascites tumor tRNA by column chromatography and measured the guanine accepting activity of each fraction with the enzymes from E. coli and Ehrlich ascites tumor. As shown in Fig. 5 , guanine-accepting activity was separated into multiple peaks, and the pattern of acceptor activity obtained with the enzyme from Ehrlich ascites tumor cells was almost identical with that obtained with the E. coli enzyme, although the extent of incorporation was much less with the Ehrlich ascites tumor enzyme. These results strongly suggest that the guanine incorporation observed in the homologous system is also due to the incorporation of guanine into undermodified tRNA having guanine instead of Q base. Ehrlich ascites tumor tRNA was fractionated with acetylated DBAE-cellulose (28) . All the guanine-accepting activity detected with the Ehrlich ascites tumor enzyme was present in the fraction eluted with buffer I (1 M NaCl/0.1 M MgCl2/0.05 M morpholine, pH 8.7) and none was found in the tRNA fraction containing Q, eluted with buffer G (0.2 M NaCl/0.05 M sodium acetate buffer, pH 5.0) (data not shown). This result also supports the above conclusion. The guanine-accepting tRNA species seem to differ in different tumor tissues. Several tRNA species act as acceptors in the guanine insertion reaction in Ehrlich ascites tumor cells, while tRNAASP is the main acceptor in rat ascites hepatoma AH7974 cells. (34) . The presence of some guanine-accepting tRNA in an established cell line of AGMK suggests that most, if not all, established lines of tissue culture cells may differ in some properties from the cells in normal tissues and organs. However, the level of guanine-accepting tRNA is much higher in simian virus 40-transformed AGMK cells than in untransformed cells. This finding coincides with a previous observation that the amount of a species of isoaccepting tRNA for aspartic acid and histidine is increased in simian virus 40-transformed and -infected AGMK cells (30) . Farkas and Chernoff (35) reported that rabbit reticulocyte tRNA accepted guanine with homologous enzyme, and suggested that the tRNA species that accepted guanine might be minor tRNAAsn and tRNAHis having guanine instead of Q. Their results agreed with ours with respect to guanine-accepting tRNA species, but we could detect little incorporation of guanine into rabbit reticulocyte tRNA. It is possible that the incorporation into reticulocytes that they observed was less than 1/20th of the amount we observed in tumor tissues.
It is unknown how undermodified tRNA is induced in tumor tissues. The primary structure of the AH7974 minor tRNAASP that accepts guanine seems to be very similar to that of major tRNA'MP, but it is still unknown whether the two tRNAAsPs have exactly the same primary structure, or whether there are minor differences in their sequences as well as in the extent of their post-transcriptional modification. It is also unknown whether 
